Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...
John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07. Tara covers the business of health ...
The Ebola outbreak in Central Africa could grow to 20,000 cases or more, depending on how quickly infected people are ...
OHRP has experienced an unprecedented exodus of ethics expertise, raising concerns about its ability to effectively protect ...
An NIH advisor told researchers gathered at the American Diabetes Association conference that MAHA goals match the agency's ...
Eli Lilly has told more than 1,000 hospitals participating in the 340B drug discount program to submit claims data over the ...
A compound named “substance God help me” by its longtime champion could benefit from RFK Jr.'s favorable views on using ...
Health insurers, providers, and consumer advocates praised the Trump administration’s long-awaited fixes to the No Surprises ...
At least 12 of my colleagues boarded planes to the American Society of Clinical Oncology conference in Chicago last week to ...
A senior NIH scientist and his research fellow were charged with smuggling vials of deactivated mpox virus into the country ...
Biomedical researchers and policy experts decried the change when it was proposed this spring. STAT’s Anil Oza has the latest ...
You're reading the web edition of STAT's ADA in 30 Seconds, from the American Diabetes Association's annual conference in New ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results